Takeda Pharmaceutical (TAK) Short-term Investments: 2018-2025

Historic Short-term Investments for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $134.4 million.

  • Takeda Pharmaceutical's Short-term Investments rose 31.82% to $134.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $134.2 million, marking a year-over-year increase of 31.82%. This contributed to the annual value of $134.4 million for FY2025, which is 28.47% up from last year.
  • According to the latest figures from FY2025, Takeda Pharmaceutical's Short-term Investments is $134.4 million, which was up 28.47% from $104.6 million recorded in FY2024.
  • Takeda Pharmaceutical's Short-term Investments' 5-year high stood at $345.2 million during FY2021, with a 5-year trough of $104.6 million in FY2024.
  • In the last 3 years, Takeda Pharmaceutical's Short-term Investments had a median value of $134.4 million in 2025 and averaged $129.5 million.
  • In the last 5 years, Takeda Pharmaceutical's Short-term Investments surged by 137.16% in 2021 and then tumbled by 34.71% in 2022.
  • Over the past 5 years, Takeda Pharmaceutical's Short-term Investments (MRY) stood at $345.2 million in 2021, then plummeted by 34.71% to $225.4 million in 2022, then crashed by 33.75% to $149.3 million in 2023, then dropped by 29.94% to $104.6 million in 2024, then increased by 28.47% to $134.4 million in 2025.
  • Its Short-term Investments was $134.4 million in FY2025, compared to $104.6 million in FY2024 and $149.3 million in FY2023.